FdaApplication
ANDA 214076
Identifiers
- fda_app_no: ANDA214076
Properties
| Property | Value |
|---|---|
| applicant_name | TRIS PHARMA INC |
| application_type | ANDA |
| approval_date | 2022-01-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 20MEQ/15ML | SOLUTION;ORAL |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 40MEQ/15ML | SOLUTION;ORAL |
2 products